Pilot Study of a Program to Support Parents and Improve Development in Infants Exposed to Cannabinoids Before Birth
Led by IDeA States Pediatric Clinical Trials Network · Updated on 2025-06-24
20
Participants Needed
3
Research Sites
11 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the INTACT Intervention program to support neurodevelopment in infants who were exposed to cannabinoids before birth. This multisite pilot feasibility study aims to test how well the program can be delivered and followed by participants, rather than measuring clinical outcomes. The research involves 20 birthing parent and infant pairs across three sites, with the study lasting 22 months including start-up, enrollment, intervention, and data analysis phases.
The intervention includes 12 monthly coaching sessions for birthing parents, combining online modules with personalized coaching based on the Play and Learn Strategies PALS method. These sessions focus on improving parenting skills such as recognizing infant signals and responding warmly to promote early language, cognitive, and social development. The study tracks recruitment success, completion rates of coaching sessions, and overall adherence to the program.
Participants will engage in monthly coaching for one year, with assessments focusing on recruitment numbers, session completion, and adherence to the intervention. Researchers collect data on how many participants complete the study and receive enough coaching sessions. The study does not assess infant clinical outcomes but will provide information for planning a larger future trial. Total study involvement spans up to 22 months from start to finish.
CONDITIONS
Brief Title
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
Research Team
S
Song Ounpraseuth, PhD
M
Matthew Henry, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
PALS Parent Coaching (Trial Intervention)
Usual Pediatric Developmental Care
What is it?
A structured, monthly behavioral coaching program (Play and Learn Strategies - PALS) delivered to birthing parents who used cannabinoids during pregnancy, using video modules and personalized virtual sessions to strengthen maternal responsiveness and promote healthy infant development.
Routine pediatric care includes scheduled well-baby visits, developmental surveillance by clinicians, and referral for additional support or intervention if neurodevelopmental concerns arise. No structured behavioral parent coaching is routinely provided for infants exposed to cannabinoids before birth.
Role in the trial
Primary intervention tested for feasibility and engagement in this population.
Not a trial arm; represents the care children would otherwise receive outside research.
Primary use or purpose
To determine if monthly personalized parent coaching sessions can improve maternal responsiveness and support better social-emotional and developmental outcomes in infants with prenatal cannabinoid exposure.
To monitor growth and neurodevelopment through regular pediatric check-ups and provide referrals or additional evaluation when developmental concerns emerge.
How is it given or performed?
Monthly video-based modules with remote personalized virtual coaching for parents, delivered over the first year after birth.
Infants attend scheduled pediatric visits (in person), where clinicians track development, offer anticipatory guidance, and screen for concerns.
Evidence status / maturity
Currently under investigation for feasibility and engagement; published adult and general literature suggest parent coaching can improve some child neurodevelopmental outcomes, but direct evidence for PALS in this specific high-risk group is not yet established.
Widely established as the recommended practice by national guidelines; ongoing evaluation identifies children with neurodevelopmental need for further services, but does not proactively intervene unless risk factors or delays are observed.
Important limitations
Evidence for benefit is not yet established in infants with prenatal cannabinoid exposure; access depends on device/internet, and participant engagement may vary.
May not provide targeted support for at-risk infants unless problems are identified; developmental delays may be missed between scheduled visits without proactive interventions.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 0 - 7Days
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Birthing parent of legal adult age as defined by state
Confirmed cannabinoid use during pregnancy by self-report
Ability to speak, read, and understand English
Delivered at a hospital where study team has access to medical records
Has parental custody of the infant
Singleton pregnancy resulting in live birth
Has an electronic device capable of streaming videos and video conferencing
Has internet access for study participation
Infant born at term (over 37 weeks gestation)
Infant is biological child of the birthing parent
You will not qualify if you...
Use of illicit drugs other than cannabinoids during pregnancy
Opiate use during pregnancy by self-report or toxicology
Prolonged hospitalization of birthing parent after delivery over 7 days
Infant with major birth defects or physical anomalies
Infant diagnosed with serious neurological or metabolic disorders during birth hospitalization
Infant had major surgery or prolonged birth hospitalization over 7 days
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Treatment
Duration - 12 months
Participants take part in the INTACT intervention program consisting of monthly online modules and personalized coaching sessions to promote early language, cognitive, and social development in their infants.
12 coaching sessions, 1 per month (online and/or remote)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Online Self-Instructional Program for Kindergarten and Elementary Teachers to Support Autistic Children and Children With Developmental Delays
Monitoring Infant Motor Skills and Cognitive Development Using Wearable Technology
Observing Typical and At-Risk Infants from 5 to 26 Months
Evaluation of the PLUSS Model for Early Detection and Support of Neurodevelopmental and Behavioral Challenges in Preschool Children with Parental and Teacher Involvement
Pilot Study of a Program to Support Parents and Improve Development in Infants Exposed to Cannabinoids Before Birth
Long-Term Study of Neurogenetic Disorders in People With Confirmed Genetic Variants Affecting Brain Development
Study of Brain Activity and Motor Imitation in Infants and Adults to Understand Early Signs of Neurodevelopmental Disorders
Behavioral Intervention to Reduce Problem Behavior in Young Children with Developmental Delays or Disabilities
Using IDEA Part C Early Intervention Services
Trial of Xylitol Chewing Gum to Prevent Periodontal Disease and Reduce Preterm Birth in Pregnant Individuals in Malawi
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The protocol for a pilot feasibility trial of Improving Neurodevelopmental ouTcomes After prenatal Cannabinoid in uTero exposure (INTACT) study for a multi-center trial.
Jessie R Maxwell, Leigh-Anne Cioffredi, Maria M Talavera-Barber...